insights_auto
Proč je WUXI06 níž 3,42%?
Prozkoumat hloubějichevron_right
WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
5,65 THB
arrow_downward
-3,42%(-0,20) 1D
12. 10., 16:40:00 GMT+7 · THB
search
Všechny symboly
| Symbol | Cena | Změna | Změna (%) |
|---|
insights_autoGenerování hlavních statistik pro WUXI06…
Otevřít
5,70 THB
Max.
5,75 THB
Min.
5,65 THB
Trž. kap.
216,75 mld.
Prům. obj.
104,18 tis.
Objem
26,14 tis.
52týd. max.
6,25 THB
52týd. min.
3,02 THB
Akcie v oběhu
4,12 mld.
Počet zaměstnanců
15 tis.
Otevřít
5,70 THB
Max.
5,75 THB
Min.
5,65 THB
Trž. kap.
216,75 mld.
Prům. obj.
104,18 tis.
Objem
26,14 tis.
52týd. max.
6,25 THB
52týd. min.
3,02 THB
Akcie v oběhu
4,12 mld.
Počet zaměstnanců
15 tis.
Zpravodajské články
Z webových zdrojů a od partnerů z oblasti zpravodajství
bloomingbit
·
před 25 minutami
XRP Treasury Firm Evernode Gains 5% in Nasdaq Debut
HME News
·
před 22 minutami
Accendra Health on notice from NYSE
Simply Wall Street
·
před 25 minutami
Palantir Technologies (PLTR) Formed Regna AI For Sovereign Defense And Infrastructure AI
Yahoo Finance
·
před 1 hodinou
A handful of tech stocks are masking an ugly S&P 500 problem
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Informace o Wuxi Biologics (Cayman) Inc. KKPS DR